Inactivation of TACC2 epigenetically represses CDKN1A and confers sensitivity to CDK inhibitors.
Lin ZR, Xia TL, Wang MY, Zhang LJ, Liu YM, Yuan BY, Zhou AJ, Yuan L, Zheng J, Bei JX, Lin DX, Zeng MS, Zhong Q.
Lin ZR, et al. Among authors: zheng j.
Med. 2025 Jan 5:100568. doi: 10.1016/j.medj.2024.12.002. Online ahead of print.
Med. 2025.
PMID: 39793578